MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ygyno.2024.07.683

Медицинская библиотека · Gynecologic oncology · 2024

Brachytherapy in vaginal cancer for organ preservation: Clinical outcome and safety from a single center experience.

Merten Ricarda, Strnad Vratislav, Karius Andre, Lotter Michael, Kreppner Stephan, Schweizer Claudia, Fietkau Rainer, Schubert Philipp

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Interstitial and/or intracavitary brachytherapy is an integral part of the treatment of vaginal cancer Brachytherapy (BT) has shown to improve local control, overall survival (OS) and disease-free survival (DFS). The aim of our study was to analyze the efficacy and safety of brachytherapy in patients with vaginal cancer.

MATERIALS AND

METHODS

Between 2000 and 2023, 27 patients with vaginal cancer in stage FIGO I-III were treated with brachytherapy with or without external beam radiotherapy (EBRT) and simultaneous chemotherapy. Brachytherapy has been performed either as PDR-brachytherapy alone with a median cumulative dose up to 62.5 Gy (EQD2 = 63.9 Gy) or with PDR-BT boost with median dose of 30.9 Gy (EQD2 = 30.4 Gy). HDR-BT was administered solely as boost with a median dose of 25.5 Gy (EQD2 = 47.8 Gy). The median dose of EBRT was 48.7 Gy and 49.4 Gy for primary and for pelvic lymph nodes.

RESULTS

Median follow-up was 39 months (2-120). 5/27 patients developed local recurrences and the 5-year cumulative local recurrence rate for whole patient population was 18.5%. 5-year OS and DFS was 90% and 68%. 5-year DFS for Stage I-II was 72% and for Stage III 65% (p = 0.933). Grade 3 late side effects of brachytherapy were documented in 3/22 patients (13.6%), one patient experienced Grade 4 toxicity (4.5%).

CONCLUSION

Brachytherapy with or without EBRT and concomitant chemotherapy for vaginal cancer is a safe and effective treatment option with excellent local control and overall survival and acceptable toxicity.

Для цитирования: Merten Ricarda, Strnad Vratislav, Karius Andre, Lotter Michael, Kreppner Stephan, Schweizer Claudia, Fietkau Rainer, Schubert Philipp. Brachytherapy in vaginal cancer for organ preservation: Clinical outcome and safety from a single center experience.. Gynecologic oncology. 2024. DOI: 10.1016/j.ygyno.2024.07.683.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.